Follow-on Biologics Market Report

China Follow-on Biologics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 21, 2023
  • PAGES：197
  • REPORT CODE：GMM1812030
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Follow-on Biologics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Samsung Biologics

    • Celltrion

    • Pfizer

    • Stada Arzneimittel AG

    • Mylan

    • Sandoz

    • Dr Reddy's Laboratories

    • Biocon

    • Teva Pahrmaceutical

    By Type:

    • Recombinant Peptides

    • Recombinant Glycosylated Proteins

    • Recombinant Non-glycosylated Proteins

    By Application:

    • Growth Hormone Deficiency

    • Autoimmune Diseases

    • Oncology

    • Other Diseases

    • Infectious Diseases

    • Blood Disorders

    • Chronic Diseases

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Follow-on Biologics Market Overview 2018-2029

    • 1.1 China Follow-on Biologics Industry Development Overview

    • 1.2 China Follow-on Biologics Industry Development History

    • 1.3 China Follow-on Biologics Industry Market Size (2018-2029)

    • 1.4 China Follow-on Biologics Market Analysis by Type from Production Side

      • 1.4.1 China Follow-on Biologics Production Volume, Production Value and Growth Rate of Recombinant Peptides (2018-2029)

      • 1.4.2 China Follow-on Biologics Production Volume, Production Value and Growth Rate of Recombinant Glycosylated Proteins (2018-2029)

      • 1.4.3 China Follow-on Biologics Production Volume, Production Value and Growth Rate of Recombinant Non-glycosylated Proteins (2018-2029)

    • 1.5 China Follow-on Biologics Market Analysis by Application from Consumption End

      • 1.5.1 China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)

      • 1.5.2 China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

      • 1.5.3 China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.4 China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

      • 1.5.5 China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.6 China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

      • 1.5.7 China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Chronic Diseases (2018-2029)

    • 1.6 China Follow-on Biologics Market Analysis by Region

      • 1.6.1 North China Follow-on Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Follow-on Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Follow-on Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Follow-on Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Follow-on Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Follow-on Biologics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Follow-on Biologics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Follow-on Biologics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Follow-on Biologics Market Status and Competition Analysis in 2023

      • 2.2.3 China Follow-on Biologics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Follow-on Biologics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Follow-on Biologics Industry Development

    Chapter 3 Follow-on BiologicsIndustry Chain Analysis

    • 3.1 Follow-on Biologics Industry Chain

    • 3.2 Follow-on Biologics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Follow-on Biologics Market

    • 3.3 Follow-on Biologics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Follow-on Biologics Market

    Chapter 4 China Follow-on Biologics Market, by Type

    • 4.1 China Follow-on Biologics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Follow-on Biologics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Follow-on Biologics Production Volume and Growth Rate, by Type

      • 4.5.1 China Follow-on Biologics Production Volume and Growth Rate of Recombinant Peptides

      • 4.5.2 China Follow-on Biologics Production Volume and Growth Rate of Recombinant Glycosylated Proteins

      • 4.5.3 China Follow-on Biologics Production Volume and Growth Rate of Recombinant Non-glycosylated Proteins

    Chapter 5 China Follow-on Biologics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Follow-on Biologics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Follow-on Biologics Market Size and Growth Rate, by Application

      • 5.5.1 China Follow-on Biologics Market Size and Growth Rate of Growth Hormone Deficiency

      • 5.5.2 China Follow-on Biologics Market Size and Growth Rate of Autoimmune Diseases

      • 5.5.3 China Follow-on Biologics Market Size and Growth Rate of Oncology

      • 5.5.4 China Follow-on Biologics Market Size and Growth Rate of Other Diseases

      • 5.5.5 China Follow-on Biologics Market Size and Growth Rate of Infectious Diseases

      • 5.5.6 China Follow-on Biologics Market Size and Growth Rate of Blood Disorders

      • 5.5.7 China Follow-on Biologics Market Size and Growth Rate of Chronic Diseases

    Chapter 6 China Follow-on Biologics Market, by Region

    • 6.1 China Follow-on Biologics Production Volume and Production Value, by Region

    • 6.2 China Follow-on Biologics Sales Volume and Sales Value, by Region

    Chapter 7 North China Follow-on Biologics Market Analysis

    • 7.1 North China Follow-on Biologics Market, by Type

    • 7.2 North China Follow-on Biologics Market, by Application

    Chapter 8 Central China Follow-on Biologics Market Analysis

    • 8.1 Central China Follow-on Biologics Market, by Type

    • 8.2 Central China Follow-on Biologics Market, by Application

    Chapter 9 South China Follow-on Biologics Market Analysis

    • 9.1 South China Follow-on Biologics Market, by Type

    • 9.2 South China Follow-on Biologics Market, by Application

    Chapter 10 East China Follow-on Biologics Market Analysis

    • 10.1 East China Follow-on Biologics Market, by Type

    • 10.2 East China Follow-on Biologics Market, by Application

    Chapter 11 Northeast China Follow-on Biologics Market Analysis

    • 11.1 Northeast China Follow-on Biologics Market, by Type

    • 11.2 Northeast China Follow-on Biologics Market, by Application

    Chapter 12 Southwest China Follow-on Biologics Market Analysis

    • 12.1 Southwest China Follow-on Biologics Market, by Type

    • 12.2 Southwest China Follow-on Biologics Market, by Application

    Chapter 13 Northwest China Follow-on Biologics Market Analysis

    • 13.1 Northwest China Follow-on Biologics Market, by Type

    • 13.2 Northwest China Follow-on Biologics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Samsung Biologics

        • 14.1.1 Samsung Biologics Company Profile

        • 14.1.2 Samsung Biologics Follow-on Biologics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Celltrion

        • 14.2.1 Celltrion Company Profile

        • 14.2.2 Celltrion Follow-on Biologics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer

        • 14.3.1 Pfizer Company Profile

        • 14.3.2 Pfizer Follow-on Biologics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Stada Arzneimittel AG

        • 14.4.1 Stada Arzneimittel AG Company Profile

        • 14.4.2 Stada Arzneimittel AG Follow-on Biologics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Mylan

        • 14.5.1 Mylan Company Profile

        • 14.5.2 Mylan Follow-on Biologics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sandoz

        • 14.6.1 Sandoz Company Profile

        • 14.6.2 Sandoz Follow-on Biologics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Dr Reddy's Laboratories

        • 14.7.1 Dr Reddy's Laboratories Company Profile

        • 14.7.2 Dr Reddy's Laboratories Follow-on Biologics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Biocon

        • 14.8.1 Biocon Company Profile

        • 14.8.2 Biocon Follow-on Biologics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Teva Pahrmaceutical

        • 14.9.1 Teva Pahrmaceutical Company Profile

        • 14.9.2 Teva Pahrmaceutical Follow-on Biologics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Follow-on Biologics Industry Research Conclusions

    • 15.2 Follow-on Biologics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Follow-on Biologics Industry Market Size (2018-2029)

    • Figure China Follow-on Biologics Production Volume, Production Value and Growth Rate of Recombinant Peptides (2018-2029)

    • Figure China Follow-on Biologics Production Volume, Production Value and Growth Rate of Recombinant Glycosylated Proteins (2018-2029)

    • Figure China Follow-on Biologics Production Volume, Production Value and Growth Rate of Recombinant Non-glycosylated Proteins (2018-2029)

    • Figure China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)

    • Figure China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Autoimmune Diseases (2018-2029)

    • Figure China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

    • Figure China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

    • Figure China Follow-on Biologics Sales Volume, Sales Value and Growth Rate of Chronic Diseases (2018-2029)

    • Figure North China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    • Figure Central China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    • Figure South China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    • Figure East China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Follow-on Biologics Market Size and Growth Rate from 2018-2029

    • Figure Follow-on Biologics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Follow-on Biologics Market Share by Type in 2018

    • Figure China Follow-on Biologics Market Share by Type in 2023

    • Figure China Follow-on Biologics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Follow-on Biologics Production Volume and Growth Rate of Recombinant Peptides (2018-2023)

    • Figure China Follow-on Biologics Production Volume and Growth Rate of Recombinant Glycosylated Proteins (2018-2023)

    • Figure China Follow-on Biologics Production Volume and Growth Rate of Recombinant Non-glycosylated Proteins (2018-2023)

    • Figure China Follow-on Biologics Market Share by Application in 2018

    • Figure China Follow-on Biologics Market Share by Application in 2023

    • Figure China Follow-on Biologics Total Market Size and Growth Rate from Consumption End

    • Figure China Follow-on Biologics Market Size and Growth Rate of Growth Hormone Deficiency (2018-2023)

    • Figure China Follow-on Biologics Market Size and Growth Rate of Autoimmune Diseases (2018-2023)

    • Figure China Follow-on Biologics Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Follow-on Biologics Market Size and Growth Rate of Other Diseases (2018-2023)

    • Figure China Follow-on Biologics Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China Follow-on Biologics Market Size and Growth Rate of Blood Disorders (2018-2023)

    • Figure China Follow-on Biologics Market Size and Growth Rate of Chronic Diseases (2018-2023)

    • Table China Follow-on Biologics Production Volume by Region (2018-2023)

    • Table China Follow-on Biologics Production Volume Share by Region (2018-2023)

    • Figure China Follow-on Biologics Production Volume Share by Region (2018-2023)

    • Table China Follow-on Biologics Production Value by Region (2018-2023)

    • Table China Follow-on Biologics Production Value Share by Region (2018-2023)

    • Figure China Follow-on Biologics Production Value Share by Region (2018-2023)

    • Table China Follow-on Biologics Sales Volume by Region (2018-2023)

    • Table China Follow-on Biologics Sales Volume Share by Region (2018-2023)

    • Figure China Follow-on Biologics Sales Volume Share by Region (2018-2023)

    • Table China Follow-on Biologics Sales Value by Region (2018-2023)

    • Table China Follow-on Biologics Sales Value Share by Region (2018-2023)

    • Figure China Follow-on Biologics Sales Value Share by Region (2018-2023)

    • Table North China Follow-on Biologics Production Volume by Type (2018-2023)

    • Table North China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Figure North China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Table North China Follow-on Biologics Sales Volume by Application (2018-2023)

    • Table North China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Figure North China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Table Central China Follow-on Biologics Production Volume by Type (2018-2023)

    • Table Central China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Figure Central China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Table Central China Follow-on Biologics Sales Volume by Application (2018-2023)

    • Table Central China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Figure Central China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Table South China Follow-on Biologics Production Volume by Type (2018-2023)

    • Table South China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Figure South China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Table South China Follow-on Biologics Sales Volume by Application (2018-2023)

    • Table South China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Figure South China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Table East China Follow-on Biologics Production Volume by Type (2018-2023)

    • Table East China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Figure East China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Table East China Follow-on Biologics Sales Volume by Application (2018-2023)

    • Table East China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Figure East China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Follow-on Biologics Production Volume by Type (2018-2023)

    • Table Northeast China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Table Northeast China Follow-on Biologics Sales Volume by Application (2018-2023)

    • Table Northeast China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Follow-on Biologics Production Volume by Type (2018-2023)

    • Table Southwest China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Table Southwest China Follow-on Biologics Sales Volume by Application (2018-2023)

    • Table Southwest China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Follow-on Biologics Production Volume by Type (2018-2023)

    • Table Northwest China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Follow-on Biologics Production Volume Share by Type (2018-2023)

    • Table Northwest China Follow-on Biologics Sales Volume by Application (2018-2023)

    • Table Northwest China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Follow-on Biologics Sales Volume Share by Application (2018-2023)

    • Table Samsung Biologics Company Profile

    • Table Samsung Biologics Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Celltrion Company Profile

    • Table Celltrion Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Stada Arzneimittel AG Company Profile

    • Table Stada Arzneimittel AG Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Sandoz Company Profile

    • Table Sandoz Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Dr Reddy's Laboratories Company Profile

    • Table Dr Reddy's Laboratories Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Follow-on Biologics Revenue, Price and Gross (2018-2023)

    • Table Teva Pahrmaceutical Company Profile

    • Table Teva Pahrmaceutical Follow-on Biologics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US